SAN FRANCISCO — Obeticholic acid maintains reduced levels of key biomarkers for primary biliary cholangitis (previously known as primary biliary cirrhosis) for up to 5 years, according to the results ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback